Back to search

Article

A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer

2024-08-19

Abstract excerpt

<h4>Summary</h4> Neuroendocrine prostate cancer (NEPC) presents a formidable clinical challenge owing to its aggressive progression and resistance to conventional therapies. A key driver of NEPC is the overexpression of MYCN , a well-established oncogene associated with neuroendocrine tumors. However, efforts to directly inhibit the N-Myc protein encoded by this gene have resulted in limited success, thereby hin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f89459d9-fe9e-5ee6-9069-c2222830ff77
DOI
10.1101/2024.08.16.607954
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancerDOI 10.1101/2024.08.16.607954
Select a neighboring publication to make it the new centre.